Cancer Research CR Mantle  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Manjeshwar, S.
Right arrow Articles by Jupe, E. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Manjeshwar, S.
Right arrow Articles by Jupe, E. R.
[Cancer Research 63, 5251-5256, September 1, 2003]
© 2003 American Association for Cancer Research


Regular Articles

Tumor Suppression by the Prohibitin Gene 3'Untranslated Region RNA in Human Breast Cancer1

Sharmila Manjeshwar, Dannielle E. Branam, Megan R. Lerner, Daniel J. Brackett and Eldon R. Jupe2

Program in Immunobiology and Cancer [S. M., D. E. B., E. R. J.], Oklahoma Medical Research Foundation; InterGenetics, Inc. [S. M., E. R. J.]; and Departments of Surgery [M. R. L., D. J. B., E. R. J.] and Pathology [E. R. J.], University of Oklahoma Health Sciences Center, and Veterans Affairs Medical Center [M. R. L., D. J. B.], Oklahoma City, Oklahoma 73104

Prohibitin is a candidate tumor suppressor gene located on human chromosome 17q21, a region of frequent loss of heterozygosity in breast cancers. We showed previously that microinjection of RNA encoded by the prohibitin gene 3'untranslated region (3'UTR) blocks the G1-S transition causing cell cycle arrest in several human cancer cell lines, including MCF7. Two allelic forms (C versus T) of the prohibitin 3'UTR exist, and carriers of the less common variant (Tallele) with a family history of breast cancer exhibited an increased risk of breast cancer. In the present study, we examined the tumor suppressor activity of the prohibitin 3'UTR in human breast cancer cells. Stable clones of MCF7 cells expressing either the C allele or the T allele RNA under the control of the cytomegalovirus promoter were isolated and compared with empty vector clones. Clones expressing the C allele RNA (UTR/C) exhibited significant suppression of growth in cell proliferation assays, inhibition of colony formation in soft agar assays, and suppression of xenograft tumor growth when implanted on nude mice, compared with either T allele expressing or empty vector clones. Immunohistochemical analyses with Ki67 staining confirmed a significant reduction in proliferation of UTR/C tumors. Thus, the C allele of prohibitin 3'UTR produces a functional RNA, whereas a single nucleotide polymorphism creates a null allele (T allele) of which the RNA product has lost activity. Our data demonstrate for the first time that an RNA molecule functions as a tumor suppressor in human breast cancer.




This article has been cited by other articles:


Home page
Acta Biochim Biophys SinHome page
H. Wang, Y. Wang, L. Sun, and D. Liu
Sequences near both termini of the C/EBP{beta} mRNA 3' untranslated region are important for its tumor suppression activity
Acta Biochim Biophys Sin, June 1, 2009; 41(6): 456 - 463.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
J. Feng, M. A. Lawson, and P. Melamed
A Proteomic Comparison of Immature and Mature Mouse Gonadotrophs Reveals Novel Differentially Expressed Nuclear Proteins that Regulate Gonadotropin Gene Transcription and RNA Splicing
Biol Reprod, September 1, 2008; 79(3): 546 - 561.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. A. Ross, Z. S. Nagy, and R. A. Kirken
The PHB1/2 Phosphocomplex Is Required for Mitochondrial Homeostasis and Survival of Human T Cells
J. Biol. Chem., February 22, 2008; 283(8): 4699 - 4713.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. L. Theiss, T. S. Obertone, D. Merlin, and S. V. Sitaraman
Interleukin-6 Transcriptionally Regulates Prohibitin Expression in Intestinal Epithelial Cells
J. Biol. Chem., April 27, 2007; 282(17): 12804 - 12812.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
A. L. Theiss, R. D. Idell, S. Srinivasan, J.-M. Klapproth, D. P. Jones, D. Merlin, and S. V. Sitaraman
Prohibitin protects against oxidative stress in intestinal epithelial cells
FASEB J, January 1, 2007; 21(1): 197 - 206.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. Lou, N. Fatima, Z. Xiao, S. Stauffer, G. Smythers, P. Greenwald, and I. U. Ali
Proteomic profiling identifies cyclooxygenase-2-independent global proteomic changes by celecoxib in colorectal cancer cells.
Cancer Epidemiol. Biomarkers Prev., September 1, 2006; 15(9): 1598 - 1606.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. Zhu, K. Fukada, H. Zhu, and N. Kyprianou
Prohibitin and Cofilin Are Intracellular Effectors of Transforming Growth Factor {beta} Signaling in Human Prostate Cancer Cells.
Cancer Res., September 1, 2006; 66(17): 8640 - 8647.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Rastogi, B. Joshi, G. Fusaro, and S. Chellappan
Camptothecin Induces Nuclear Export of Prohibitin Preferentially in Transformed Cells through a CRM-1-dependent Mechanism
J. Biol. Chem., February 3, 2006; 281(5): 2951 - 2959.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
Y. Fu, N. Luo, R. L. Klein, and W. T. Garvey
Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation
J. Lipid Res., July 1, 2005; 46(7): 1369 - 1379.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
D. Jenkins, M. Bitner-Glindzicz, S. Malcolm, C.-C. A. Hu, J. Allison, P. J.D. Winyard, A. M. Gullett, D. F.M. Thomas, R. A. Belk, S. A. Feather, et al.
De Novo Uroplakin IIIa Heterozygous Mutations Cause Human Renal Adysplasia Leading to Severe Kidney Failure
J. Am. Soc. Nephrol., July 1, 2005; 16(7): 2141 - 2149.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
T. De Celle, F. Vanrobaeys, P. Lijnen, W. M. Blankesteijn, S. Heeneman, J. Van Beeumen, B. Devreese, J. F. M Smits, and B. J. A Janssen
Alterations in mouse cardiac proteome after in vivo myocardial infarction: permanent ischaemia versus ischaemia-reperfusion
Exp Physiol, July 1, 2005; 90(4): 593 - 606.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
P. M. Harrison, D. Zheng, Z. Zhang, N. Carriero, and M. Gerstein
Transcribed processed pseudogenes in the human genome: an intermediate form of expressed retrosequence lacking protein-coding ability
Nucleic Acids Res., April 28, 2005; 33(8): 2374 - 2383.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.